Morgan Lekstrom

Chairman

Morgan Lekstrom is the Co-Founder and Chairman of Streamex, and current CEO of Premium Resources a publicly traded critical metals company.  Mr. Lekstrom brings nearly two decades of experience in the global commodities sector to the forefront of blockchain innovation. With a deep understanding of commodity operations, corporate strategy, and engineering execution, Morgan is passionate about bridging the gap between traditional resource industries and emerging digital technologies.

Morgan is a strong advocate for the transformative potential of real-world asset tokenization in the commodity sector. He believes blockchain can drive transparency, unlock new forms of capital, and improve efficiency across the entire commodity value chain from development to production and asset ownership. Through his leadership at Streamex, Morgan is committed to pioneering the tokenization of commodities and proving how blockchain can modernize one of the world’s oldest and largest industries on the planet.

Over his 17+ year career, Morgan has built a reputation for delivering operational success and strategic value. Most recently, he led the creation and growth of NexGold Mining Corp, where he executed a bold vision to develop two near-term Canadian gold mines. Morgan’s global experience spans senior technical and leadership roles, including with Freeport McMoRan at the Grasberg site in Indonesia, Rio Tinto at the Oyu Tolgoi Project in Mongolia, and Golden Star Resources in Ghana, where he supported the redevelopment of an underground mine. He also served as Engineering Manager at Sabina Gold & Silver Corp., leading early execution phases of the Back River Marine Laydown Project in Northern Canada.

Henry McPhie

Henry McPhie

CEO

Henry McPhie is a seasoned entrepreneur and visionary technologist with a strong track record of building innovative companies at the intersection of blockchain and finance. He is the Co-Founder and Chief Executive Officer of Streamex, where he leads the company's mission to revolutionize real-world asset tokenization and bring commodities on-chain through cutting-edge blockchain solutions.

Prior to founding Streamex, Henry Founded Lynx Web3 Solutions, a blockchain incubation and software development firm that supported early-stage Web3 projects with the tools, infrastructure, and strategic guidance needed to scale. Henry was also the founder of FatCats Capital, a Solana-based NFT project that quickly rose to become the third largest NFT project in the world at the time of its launch. Under his leadership, FatCats cultivated a vibrant global community of over 100,000 members, setting new standards for value creation in the NFT space.

With a background in engineering, Henry holds a degree in Mining Engineering from McGill University. He brings a rare combination of technical acumen, product vision, and community-building expertise to every venture he leads, and remains deeply committed to advancing the adoption and utility of blockchain technology and tokenization across industries.

Anthony Amato

Anthony Amato

Mr. Anthony Amato is a business leader and entrepreneurial thinker with an intuitive ability to rapidly assess challenges and identify growth opportunities. He quickly sees organizational vision and understands goals, taking appropriate ownership and action required to guide the team, achieving aggressive targets and performance levels. Anthony has hands-on executive skills at engaging and influencing key stakeholders to not only grow business but also to optimize profits.

Anthony founded InQuest Science in March 2017 and then acquired Bridge Associates International Pharmaceutical Consulting in March 2020. He is the former director of Sales for Mesa Labs (MLAB) in Denver CO, a Nasdaq listed corporation that specializes in providing quality control products and services to ensure the safety and efficacy of equipment used in hospitals, pharmaceutical, medical device manufacturers, blood banks, laboratories, pharmacies, and industrial facilities.

In July of 1999 he founded Amega Scientific Corporation. He grew the company from a startup operation to a worldwide industry leader. Anthony developed and managed a staff with multiple North American offices, establishing R&D, production, logistics, administration, and sales. Clients included pharmaceutical, biotech, hospitals, government facilities, and research universities. Amega Scientific was a leading innovator for the Environmental Monitoring System industry. Amega Scientific was an ISO 17025 corporation instituting GXP requirements. Amega Scientific was acquired by Mesa Labs in November 2013.

Mr. Amato graduated from Glassboro State College (New Jersey) in 1989, with a dual degree in business management and finance. Mr. Amato’s outstanding interpersonal, business development, team building, and management skills make him an asset to the Company’s board of directors.

Chris Baer

Chris Baer

Director

Mr. Chris Baer brings more than 25 years of commercial experience in the medical device space across both large publicly held and smaller privately held organizations. He currently serves as the Chief Commercial Officer at CDL Nuclear Technologies. He started in this role in April 2022 and prior to that from June 2019 to April 2022 he served as the vice president of commercial operations at Impulse Dynamics. He also held several commercial leadership roles in the cardiac rhythm management and electrophysiology space including Vice President and general manager at St. Jude Medical / Abbott. Mr. Baer holds a pharmacy degree from The University of Pittsburgh. Mr. Baer’s extensive experience in the electrophysiology medical device space makes him a valuable member of our Board.

Steven E. Abelman

Steven E. Abelman

Director

Mr. Steven E. Abelman has more than 30 years of commercial litigation experience and currently serves as a shareholder for Brownstein Hyatt Farber Schreck in Denver, CO.  Mr. Abelman is a trusted advisor and trial counsel to banks, lending institutions and a variety of organizations and recognized by his peers for his expertise at the intersection of litigation and transactional law.  Yearly recognized as a top bankruptcy attorney, Mr. Abelman has been a frequent lecturer on bankruptcy and creditors’ rights topics, and combines sage advice, objective counsel with effective advocacy. The combination of over 30 years of handling loan workouts and dissolutions provide him with unique transactional aptitude for a commercial litigator. He serves as a trusted advisor and trial counsel to many banks and other lending institutions, as well as to businesses of various sizes.

Mr. Abelman is especially known for his success in representing creditors in large commercial bankruptcy cases, receiverships, and foreclosures, defending banks in lender liability cases, and representing both debtors and creditors in workout scenarios and distressed asset sales. He also represents parties regarding UCC matters and equipment lessors. Mr. Abelman graduated with a J.D. in 1984 from Whittier College Law School and a B.S. in 1979 from University of Chicago; was admitted to the U.S. Supreme Court, U.S. District Court, District of Colorado in 1984. Mr. Abelman’s extensive legal experience makes him an asset to the Board.

Donald F. Browne, C.P.A.

Donald F. Browne, C.P.A.

Director

Mr. Donald F. Browne, C.P.A. is a graduate of La Salle College, 1972, with a B.S. in accounting and later became licensed as a certified public accountant from the state of New Jersey in 1980.  Mr. Browne’s career has included being employed as a divisional controller of Caddy Corporation of America and a controller for Full Line Foods, Inc.

In 1990, Mr. Browne’s career then transitioned to public accounting, a field in which he launched his own firm (which he continues to run and operate). Mr. Browne specializes in business accounting, including financial and tax reporting for businesses of several different industries and professions, concentrations in federal and state tax audits. Mr. Browne’s tax and financial expertise makes him a valuable asset to our Board of Directors.